IssuerAnnouncementDetailsV2Portlet
Actions
Nahdi Medical Co. Announces the Board of Director’s Decision to Distribute Cash Dividends for First Half of 2025
| Element List | Explanation |
|---|---|
| Introduction | Nahdi Medical Company announces the Board of Directors' resolution to distribute cash dividends to shareholders for the First Half of 2025 |
| Date of the board’s decision | 2025-07-29 Corresponding to 1447-02-04 |
| The Total amount distributed | SAR 338,000,000 |
| Number of Shares Eligible for Dividends | 130,000,000 Shares |
| Dividend per share | SAR 2.60 |
| Percentage of Dividend to the Share Par Value (%) | 26 |
| Eligibility date | 2025-08-12 Corresponding to 1447-02-18 |
| Distribution Date | 2025-08-26 Corresponding to 1447-03-03 |
| The name of other official authorities and the details of their non-refusal to the recommendation or decision | N/A |
| Additional Information | The company would like to announce to its valued shareholders that dividends will be distributed by automatically depositing into their investment accounts linked to the shareholders’ portfolios at all banks through Edaa Securities Center Company. We would like to draw the attention of the non-resident foreign investors that the cash dividend distribution which is transferred by the resident financial broker is subject to withholding tax of 5%, in accordance with the provisions of article (68) of the income tax law and article (63) of its implementing For Nahdi’s shareholders who have not collected their dividends for the previous periods, they may contact the Investor Relations (IR) team via email or phone for assistance. The company calls on its valued shareholders to update their data and ensure that bank account numbers are linked to investment portfolios to ensure that their profits reach without a delay. In case of any inquiries or further details, please contact investor relations at (+966 12 653 53 53 or +966 55 631 5822) during working hours or email us at: IR@nahdi.sa |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
Share
Company Performance
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions